CD56 EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA - A PREDICTIVE INDICATOR OF RELAPSE?

被引：0
|
作者：
Ramalheira, S. [1 ]
Moreira, C. [1 ]
Ferreira, C. [1 ]
Leite, L. [1 ]
Pereira, D. [1 ]
Nunes, M. [1 ]
Brito, M. [1 ]
Silva, P. [1 ]
Silva, R. [1 ]
Martins, A. [1 ]
Moreira, I. [1 ]
Oliveira, I. [1 ]
Viterbo, L. [1 ]
Domingues, N. [1 ]
Chacim, S. [1 ]
Sousa, E. [2 ]
Godinho, I. [2 ]
Martins, G. [2 ]
Mendes, C. [3 ]
Santo, A. [1 ]
Mariz, J. [1 ]
机构：
[1] Inst Portugues Oncol Porto, EPE, Oncohematol, Porto, Portugal
[2] Inst Portugues Oncol Porto, EPE, Unidade Citometria Fluxo, Serv Hematol Lab, Porto, Portugal
[3] Inst Portugues Oncol Porto, EPE, Serv Hematol Lab, Porto, Portugal
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1263
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [31] CD56 expression in acute myeloid leukemia (AML) with monocytic differentiation: Association with complex karyotype
    Uherova, P
    Roulston, D
    Finn, WG
    Valdez, R
    Schnitzer, B
    Ross, CW
    MODERN PATHOLOGY, 2002, 15 (01) : 267A - 268A
  • [32] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis
    D Raspadori
    D Damiani
    M Lenoci
    D Rondelli
    N Testoni
    G Nardi
    C Sestigiani
    C Mariotti
    S Birtolo
    M Tozzi
    F Lauria
    Leukemia, 2001, 15 : 1161 - 1164
  • [33] Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
    Montesinos, Pau
    Rayon, Chelo
    Vellenga, Edo
    Brunet, Salut
    Gonzalez, Jose
    Gonzalez, Marcos
    Holowiecka, Aleksandra
    Esteve, Jordi
    Bergua, Juan
    Gonzalez, Jose D.
    Rivas, Concha
    Tormo, Mar
    Rubio, Vicente
    Bueno, Javier
    Manso, Felix
    Milone, Gustavo
    de la Serna, Javier
    Perez, Inmaculada
    Perez-Encinas, Manuel
    Krsnik, Isabel
    Ribera, Josep M.
    Escoda, Lourdes
    Lowenberg, Bob
    Sanz, Miguel A.
    BLOOD, 2011, 117 (06) : 1799 - 1805
  • [34] Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
    Tianqi Liang
    Zhiyong Peng
    Chunfu Li
    Junbin Huang
    Huabin Wang
    Chaoke Bu
    Jian Li
    Yongzhi Zheng
    Xiaoqin Feng
    Huiping Li
    Chun Chen
    BMC Cancer, 22
  • [35] Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
    Liang, Tianqi
    Peng, Zhiyong
    Li, Chunfu
    Huang, Junbin
    Wang, Huabin
    Bu, Chaoke
    Li, Jian
    Zheng, Yongzhi
    Feng, Xiaoqin
    Li, Huiping
    Chen, Chun
    BMC CANCER, 2022, 22 (01)
  • [36] The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Anthracycline Drug Combinations
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    Karandikar, N. J.
    Fuda, F. F.
    LABORATORY INVESTIGATION, 2012, 92 : 359A - 359A
  • [37] The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Anthracycline Drug Combinations
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    Karandikar, N. J.
    Fuda, F. F.
    MODERN PATHOLOGY, 2012, 25 : 359A - 359A
  • [38] Specific skin manifestations in CD56 positive acute myeloid leukemia
    Kuwabara, H
    Nagai, M
    Yamaoka, G
    Ohnishi, H
    Kawakami, K
    JOURNAL OF CUTANEOUS PATHOLOGY, 1999, 26 (01) : 1 - 5
  • [39] CD56 EXPRESSION AS A PROGNOSTIC INDICATOR IN PEDIATRIC AML: A SINGLE CENTRE REVIEW
    Gibson, Paul
    Baker, Jillian
    Abdelhaleem, Mohamed
    Johnston, Keely
    Abla, Oussama
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 828 - 828
  • [40] Leukemia Cutis from CD56 Positive, Myeloperoxidase Negative Acute Myeloid Leukemia
    Abdou, Asmaa Gaber
    Seleit, Iman
    Bakry, Ola Ahmed
    Abd Elwahed, Moshira Mohammed
    ACTA DERMATOVENEROLOGICA CROATICA, 2013, 21 (03) : 189 - 192
12345